Prescription Drug List – Maintenance: May 10, 2021
Health Canada's Drug Health Product Register (DHPR) will undergo a server update and will be unavailable from 8 AM until 12 PM on Monday, May 10th, 2021. During that time, stakeholders may email us for...
View ArticleNotice: Prescription Drug List (PDL): Multiple Additions
Documents to announce multiple updates to the Prescription Drug List.
View ArticleNotice of intent to amend: Prescription Drug List (PDL): Epinephrine (Topical...
Notice to announce the intent to add epinephrine topic solution with a qualifier on the Prescription Drug List.
View ArticleNotice: Prescription Drug List (PDL): Casirivimab and Imdevimab (COVID-19)
Document to announce the addition of Casirivimab and Imdevimab to the Prescription Drug List.
View ArticleDrug and medical device highlights 2020: Helping you maintain and improve...
Learn about the new drugs and medical devices that Health Canada approved for sale in Canada, the information we published about these products, and our other accomplishments in 2020.
View ArticleNotice: Prescription Drug List (PDL): Sotrovimab (COVID-19)
Document to announce the addition of Sotrovimab to the Prescription Drug List.
View ArticleNotice of Consultation on the Prescription Drug List (PDL): Brimonidine
Documents to announce notice of consultation for brimonidine.
View ArticleAccess Consortium: Alignment with ICMRA consensus on immunobridging for...
This statement discusses factors that support the Access Consortium’s alignment with International Coalition of Medicines Regulatory Authorities ICMRA consensus on immunobridging for authorizing...
View ArticleAstraZeneca Vaxzevria COVID-19 vaccine brand name change through the Interim...
On September 16, 2021, the AstraZeneca’s brand name will change to Vaxzevria. This change is authorized under the Interim Order respecting the importation, sale and advertising of drugs for use in...
View ArticleModerna Spikevax COVID-19 vaccine brand name authorization and transition...
On September 16, 2021, Health Canada authorized the Moderna COVID-19 vaccine under the amended Food and Drug Regulations. The vaccine has also had a brand name change, Moderna COVID-19 vaccine will now...
View ArticlePfizer-BioNTech Comirnaty COVID-19 vaccine brand name authorization and...
On September 16, 2021, Health Canada authorized the Pfizer BioNTech COVID-19 vaccine under the amended Food and Drug Regulations. The vaccine has also had a brand name change, Pfizer BioNTech COVID-19...
View ArticlePrescription status of edaravone and personal importation: Notice of update
Health Canada is extending access to the ALS treatment edaravone by personal importation until April 1st, 2022.
View ArticleMid-year update: Health products approved in 2021
Learn about our work to support Canada's response to COVID-19, the new drugs, medical devices, over-the counter and natural health products that Health Canada approved for sale in Canada, as well as...
View ArticleGuidance for market authorization requirements for COVID-19 drugs
This document provides guidance to drug manufacturers seeking authorization for their drug manufactured, sold, or represented for use in relation to COVID-19. This guidance should be read along with...
View ArticleNotice: Prescription Drug List (PDL): Brimonidine
Documents to announce notice of intent to amend for brimonidine.
View ArticleNotice: Prescription Drug List (PDL): Epinephrine (Topical Solution)
Notice to announce the addition of epinephrine topic solution with a qualifier to the Prescription Drug List.
View ArticleNotice of Consultation on the Prescription Drug List (PDL): Betaine
Notice of Consultation on the Prescription Drug List (PDL) for Betaine.
View ArticleCOVID-19: Nirmatrelvir and ritonavir (Paxlovid) treatment authorized for use...
Canada authorizes Paxlovid treatment for use against COVID-19.
View ArticleNotice: Nirmatrelvir (COVID-19) added to Prescription Drug List (PDL)
Document to announce the addition of Nirmatrelvir to the Prescription Drug List.
View ArticleNotice: Prescription Drug List (PDL): Metamizole (dipyrone)
Notice of Intent to Amend the Prescription Drug List: Metamizole (dipyrone).
View Article
